Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (241-250 of 560) with videos related to

Pageof 56
Sort By:
Blood|November 14, 1997
Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective studyA Locasciulli, M Testa, M G Valsecchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205T Li, P J Christos, J A Sparano, et al.
Annals of Hematology|December 7, 2024
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomesDarshi Shah, Francesco Sparano, Catherine Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast CancerJesus D Anampa, Daniel L Flynn, Cynthia Leary, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic reviewCarlos González-Vivas, Pau Soldevila-Matías, Olga Sparano, et al.
Breast Cancer Research and Treatment|December 4, 2010
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studiesHenri Roché, Pierfranco Conte, Edith A Perez, et al.
Clinical Breast Cancer|March 17, 2004
Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancerJoshua P Raff, Lakshmi Rajdev, Umekalsoom Malik, et al.
Journal of Geriatric Oncology|January 30, 2014
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancerLinda T Vahdat, Eduard Vrdoljak, Henry Gómez, et al.
Revista Brasileira De Epidemiologia = Brazilian Journal of Epidemiology|August 18, 2016
Incidence and causes of lower-limb amputations in the city of Ribeirão Preto from 1985 to 2008: evaluation of the medical records from 3,274 casesBruna Maria Bueno Barbosa, Rosane Aparecida Monteiro, Lucas Françolin Sparano, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
Pageof 56

Showing results (241-250 of 560) with videos related to

Sort By:
Pageof 56
Blood|November 14, 1997
Morbidity and mortality due to liver disease in children undergoing allogeneic bone marrow transplantation: a 10-year prospective studyA Locasciulli, M Testa, M G Valsecchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205T Li, P J Christos, J A Sparano, et al.
Annals of Hematology|December 7, 2024
Patient-reported outcome domains in multiple myeloma randomized controlled trials and association with survival outcomesDarshi Shah, Francesco Sparano, Catherine Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast CancerJesus D Anampa, Daniel L Flynn, Cynthia Leary, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 11, 2019
Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic reviewCarlos González-Vivas, Pau Soldevila-Matías, Olga Sparano, et al.
Breast Cancer Research and Treatment|December 4, 2010
Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studiesHenri Roché, Pierfranco Conte, Edith A Perez, et al.
Clinical Breast Cancer|March 17, 2004
Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancerJoshua P Raff, Lakshmi Rajdev, Umekalsoom Malik, et al.
Journal of Geriatric Oncology|January 30, 2014
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancerLinda T Vahdat, Eduard Vrdoljak, Henry Gómez, et al.
Revista Brasileira De Epidemiologia = Brazilian Journal of Epidemiology|August 18, 2016
Incidence and causes of lower-limb amputations in the city of Ribeirão Preto from 1985 to 2008: evaluation of the medical records from 3,274 casesBruna Maria Bueno Barbosa, Rosane Aparecida Monteiro, Lucas Françolin Sparano, et al.
JAMA Oncology|July 29, 2018
Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical TrialJoseph Sparano, Anne O'Neill, Katherine Alpaugh, et al.
Pageof 56